~$32–35B
Japan device market 2026
#3
Largest device market globally
29.3%
Population aged 65+
~12 months
Typical PMDA Shonin review
Japan Medical Device Market Overview
Japan is the world's third-largest medical device market at approximately US$32–35 billion in 2026, driven by the most aged population on earth — 29.3% over 65 — universal insurance coverage, and one of the highest per-capita imaging and endoscopy densities globally.
Domestic champions lead specific categories: Terumo (vascular, blood management), Olympus (global endoscopy monopoly-scale share), Nipro (dialysis, injectables), Canon Medical and Fujifilm (imaging), Asahi Intecc (guidewires), Sysmex (hematology IVD), and Hoya (endoscopy, optics). Yet Japan imports roughly half its devices — US and European majors hold strong positions in orthopaedics, cardiology, and surgical robotics.
Approval runs through the PMDA: Ninsho (certification) for controlled Class II devices via registered certification bodies, and Shonin (approval) for higher-risk devices — typically ~12 months for new devices with foreign clinical data increasingly accepted. Reimbursement listing under MHLW's functional category system, with biennial price revisions and the Foreign Average Price rule, defines the commercial ceiling.
Top Medical Device Companies in Japan
The following table lists the major medical device companies operating in Japan — including local manufacturers, multinational offices, regional players, and leading distributors.
| Company | HQ |
|---|---|
| Terumo | Japan |
| Olympus | Japan |
| Nipro | Japan |
| Canon Medical Systems | Japan |
| Fujifilm Healthcare | Japan |
| Sysmex | Japan |
| Asahi Intecc | Japan |
| Hoya | Japan |
| Nihon Kohden | Japan |
| Omron Healthcare | Japan |
| Medtronic Japan | USA / Ireland |
| Johnson & Johnson MedTech Japan | USA |
| Abbott Japan | USA |
| Boston Scientific Japan | USA |
| Siemens Healthineers Japan | Germany |
| GE HealthCare Japan | USA |
| Stryker Japan | USA |
| Suzuken / Medipal (device arms) | Japan |
Planning research in Japan?
Primary research, market access & HEOR. Proposals within 48 hours.
BioNixus market research
Commission custom Japan fieldwork
Book a 30-minute briefing to align on PMDA pathway intelligence, stakeholder mapping, and competitive tracking for Japan.
List of Medical Device Companies in Japan by Category
Japan medical device companies span local manufacturers, multinational corporation offices, regional suppliers, and key distributors.
Local Manufacturers
Domestic manufacturers dominate endoscopy, imaging, monitoring, IVD, and interventional consumables: Terumo, Olympus, Nipro, Canon Medical, Fujifilm, Sysmex, Asahi Intecc, Hoya, Nihon Kohden, and Omron.
- ✓ Terumo
- ✓ Olympus
- ✓ Nipro
- ✓ Canon Medical Systems
- ✓ Fujifilm Healthcare
- ✓ Sysmex
- ✓ Asahi Intecc
- ✓ Hoya
- ✓ Nihon Kohden
- ✓ Omron Healthcare
Multinational Offices
US and European majors — Medtronic, J&J MedTech, Abbott, Boston Scientific, Siemens Healthineers, GE HealthCare, Stryker — supply roughly half the market, strongest in orthopaedics, cardiology, and robotics.
- ✓ Medtronic Japan
- ✓ Johnson & Johnson MedTech Japan
- ✓ Abbott Japan
- ✓ Boston Scientific Japan
- ✓ Siemens Healthineers Japan
- ✓ GE HealthCare Japan
- ✓ Stryker Japan
Regional Players
Category specialists such as JMS, Kaneka, and Toray Medical hold strong niches in dialysis, interventional, and blood purification.
Distributors
Device distribution runs through dealer networks tied to Suzuken, Medipal, and regional specialty dealers — most foreign entrants appoint a Marketing Authorization Holder (MAH/D-MAH) plus dealers.
- ✓ Suzuken / Medipal (device arms)
Medical Device Companies in Japan: PMDA Regulatory Landscape
Pharmaceuticals and Medical Devices Agency (PMD Act; MHLW sets reimbursement) is Japan's medical device regulator.
Regulatory Authority
Pharmaceuticals and Medical Devices Agency (PMD Act; MHLW sets reimbursement) (PMDA) oversees registration, quality control, pricing, vigilance, and import licensing.
Registration Timeline
Ninsho certification 4–6 months; Shonin approval ~12 months for new devices
Renewal Period
No routine re-approval; QMS conformity every 5 years
Pricing Model
MHLW functional-category reimbursement with biennial price revisions and Foreign Average Price cap
Key Registration Requirements
- ✓Marketing Authorization Holder (MAH or Designated MAH) in Japan
- ✓Class-based pathway: Todokede notification, Ninsho certification, or Shonin approval
- ✓QMS ordinance (ISO 13485-based) conformity assessment
- ✓Japanese-language labelling and UDI
- ✓Reimbursement listing application to MHLW (functional category or new-category C1/C2)
- ✓Post-market GVP/GQP obligations
Market Access Note
The commercial constraint in Japan is pricing, not approval: MHLW's biennial revisions cut listed prices, and the Foreign Average Price rule caps reimbursement at 1.25–1.5x the average of US/EU prices. New-function C1/C2 categories can earn premiums; foreign clinical data is broadly accepted, and Sakigake/priority review accelerates innovative devices.
Japan Medical Device Market Growth Drivers
Super-Aged Demographics
29.3% of Japanese are 65+ — sustained volume growth in cardiology, orthopaedics, and chronic monitoring.
Surgical Robotics Expansion
Reimbursed robotic procedures keep expanding; Medicaroid's hinotori adds domestic competition to da Vinci.
Endoscopy & Early Cancer Screening
National screening programs sustain the world's densest endoscopy market — Olympus, Fujifilm, Hoya home turf.
Imaging AI & SaMD
PMDA's SaMD pathway and imaging AI reimbursement additions open software-driven categories.
Home & Remote Care
Government policy shifts care to home settings — monitoring, dialysis, and telehealth devices benefit.
Domestic Innovation Policy
METI/AMED funding and priority review push Japanese-origin innovation in regenerative and robotic devices.
How BioNixus Supports Medical Device Companies in Japan
BioNixus is a healthcare market research company with primary-research capability in Japan and cross-market benchmarking against GCC, USA, and European markets. We help pharma, biotech, and medtech companies with:
Physician & KOL Research
Japanese-language fieldwork with surgeons, cardiologists, and endoscopists across university and community hospitals.
Reimbursement & Pricing Research
Functional-category mapping, C1/C2 premium assessment, and biennial revision impact modelling.
Distributor & MAH Assessment
D-MAH selection support and dealer network evaluation for market entry.
Japan vs Global Benchmarking
Launch-sequencing research weighing Japan against US, EU, and Asian market entries.
Frequently Asked Questions
What are the top medical device companies in Japan?
Domestic leaders are Terumo, Olympus, Nipro, Canon Medical, Fujifilm Healthcare, Sysmex, Asahi Intecc, Hoya, Nihon Kohden, and Omron Healthcare. Among foreign MNCs, Medtronic, J&J MedTech, Abbott, Boston Scientific, GE HealthCare, Siemens Healthineers, and Stryker hold the largest Japan franchises.
How big is Japan's medical device market?
Approximately US$32–35 billion in 2026 — the third-largest globally after the USA and China — growing 3–4% annually on demographics and technology adoption, with roughly half of demand met by imports.
How does PMDA device approval work?
Japan uses three class-based routes: Todokede self-notification for Class I, Ninsho third-party certification for controlled Class II (4–6 months), and PMDA Shonin approval for higher-risk devices (~12 months for new devices). A Japan-based Marketing Authorization Holder (MAH or D-MAH) is mandatory.
How does device reimbursement work in Japan?
Devices are reimbursed under MHLW functional categories. Existing-category products take the listed price; novel devices apply for C1/C2 new-function categories with possible premiums. Prices are revised (usually downward) every two years, and the Foreign Average Price rule caps prices relative to US/EU averages.
Can foreign device companies sell directly in Japan?
Yes — either by establishing a subsidiary as MAH or appointing a Designated MAH (D-MAH), then selling through Japan's dealer networks. Foreign clinical data is broadly accepted, but Japanese-language labelling, QMS conformity, and local vigilance are required.
Which segments are growing fastest in Japan?
Surgical robotics, SaMD/imaging AI, structural heart and electrophysiology, CGM, and home-care devices are the fastest growers — all supported by reimbursement additions and Japan's aging demographics.
Data Sources & Methodology
This guide aggregates publicly available information from:
- PMDA approval and certification databases
- MHLW reimbursement price listings
- JFMDA (Japan Federation of Medical Devices Associations) statistics
- Company filings (TSE-listed manufacturers)
- BioNixus proprietary research (Japan, 2024–2026)
Company lists are editorial snapshots, not endorsements; market sizes are BioNixus estimate ranges synthesised from regulator and industry sources. For customised market intelligence on Japan, contact our team.